Need help finding what you are looking for?
Contact Us
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424066
PUBLISHER: Polaris Market Research | PRODUCT CODE: 1424066
Advanced Therapy Medicinal Products CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others); By Phase; By Indication; By Region; Segment Forecast, 2024 - 2032
PUBLISHED:
PAGES: 116 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The global advanced therapy medicinal products CDMO market size is expected to reach USD 26.27 billion by 2032, according to a new study by Polaris Market Research. The report "Advanced Therapy Medicinal Products CDMO Market Share, Size, Trends, Industry Analysis Report, By Product (Gene Therapy, Cell Therapy, Tissue Engineered, Others); By Phase; By Indication; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The evolution of numerous diseases among the population and the ability to cure chronic health issues with the prevailing medicines is compelling researchers and government institutions to invest in genetic medicine and cell and tissue therapies. This ongoing trend is facilitating a compatible environment for pharmaceutical companies to innovate new therapies, driving the need for organizations that have the required infrastructure for the development, testing, and manufacturing of new therapies, necessitating the assistance of contract development and manufacturing organizations (CDMO).
The rising government initiatives to regulate the pharmaceutical industry are showing a positive impact on the advanced therapy medicinal products CDMO market growth opportunities. In September 2023, UK CDMO Rentschler Biopharma SE received approval to develop and supply adeno-associated virus vectors (AAV) for gene therapy, including bioprocessing and cGMP production, from the Medicines & Healthcare Products Regulatory Agency.
The growing strategic collaborations and partnerships to expand the research and development activities towards treating health problems are positively influencing the ATMP CDMO market. With the Histocell partnership, Reprocell will produce advanced therapies and medicinal products generated from mesenchymal stem cells.
Cell and gene therapy production is showing a positive outlook in the market. According to the Gene, Cell, & RNA Therapy Landscape Report, in Q3 2023, 27 gene therapies, 26 RNA therapies, and 65 non-genetically modified cell therapies, received approval for clinical use. The total number of gene therapies in phase 1 Q3 registered growth by 7% compared to Q1. This trend is demonstrating the potential demand to produce advanced therapeutic medicinal products, boosting the need for CDMO in the coming years.
The tissue engineering industry is gaining momentum in the marketplace, driven by its profound scope in the replacement, repair, and regeneration of tissues, which are used to cure skin, heart, liver, and lung tissue-related health problems. The rising research activities on the development of tissue engineering therapies are expected to drive the advanced therapy medicinal products CDMO market.
Advanced Therapy Medicinal Products CDMO Market Report Highlights
Gene therapy segment is anticipated to witness the highest growth in the coming years due to the increasing clinical trials on gene therapies.
Phase I segment accounted for the largest revenue share, owing to the rise in number of therapeutic developments.
Oncology segment held the largest share, due to the rising number of cancer patients and its varied forms
Asia pacific is projected to register the fastest growth during the forecast period, attributable to the growing investments in cell and gene therapies.
The global players include AGC Biologics, Bio Elpida, BlueReg, Catalent, Celonic, CGT Catapult, Lonza, Medicine Patheon, & Minaris Regenerative.
Polaris Market Research has segmented the advanced therapy medicinal products CDMO market report based on product, phase, indication and region:
Advanced Therapy Medicinal Products CDMO, Product Outlook (Revenue - USD Billion, 2019 - 2032)
- Cell Therapy
- Gene Therapy
Advanced Therapy Medicinal Products CDMO, Phase Outlook (Revenue - USD Billion, 2019 - 2032)
- Phase I
- Phase II
- Phase III
- Phase IV
Advanced Therapy Medicinal Products CDMO, Indication Outlook (Revenue - USD Billion, 2019 - 2032)
- Oncology
- Cardiology
- Central nervous system
- Musculoskeletal
- Infectious disease
- Dermatology
- Endocrine, metabolic, genetic
- Immunology & inflammation
- Ophthalmology
- Hematology
- Gastroenterology
- Others
Advanced Therapy Medicinal Products CDMO, Regional Outlook (Revenue - USD Billion, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Product Code: PM4326
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global Advanced Therapy Medicinal Products CDMO Market Insights
- 4.1. Advanced Therapy Medicinal Products CDMO Market - Phase Snapshot
- 4.2. Advanced Therapy Medicinal Products CDMO Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. The rising cell and gene-based therapies in biotechnology
- 4.2.1.2. The higher production capability of CDMOs
- 4.2.2. Restraints and Challenges
- 4.2.2.1. The talent shortage pertaining to ATMP production is likely to impede market growth
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Advanced Therapy Medicinal Products CDMO Market Phase Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global Advanced Therapy Medicinal Products CDMO Market, by Indication
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 5.3. Oncology
- 5.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Oncology, by Region, 2019-2032 (USD Billion)
- 5.4. Cardiology
- 5.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Cardiology, by Region, 2019-2032 (USD Billion)
- 5.5. Central nervous system
- 5.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Central nervous system, by Region, 2019-2032 (USD Billion)
- 5.6. Musculoskeletal
- 5.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Musculoskeletal, by Region, 2019-2032 (USD Billion)
- 5.7. Infectious disease
- 5.7.1. Global Advanced Therapy Medicinal Products CDMO Market, by Infectious disease, by Region, 2019-2032 (USD Billion)
- 5.8. Dermatology
- 5.8.1. Global Advanced Therapy Medicinal Products CDMO Market, by Dermatology, by Region, 2019-2032 (USD Billion)
- 5.3. Endocrine, metabolic, genetic
- 5.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Endocrine, metabolic, genetic, by Region, 2019-2032 (USD Billion)
- 5.4. Immunology & inflammation
- 5.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Immunology & inflammation, by Region, 2019-2032 (USD Billion)
- 5.5. Ophthalmology
- 5.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Ophthalmology, by Region, 2019-2032 (USD Billion)
- 5.6. Hematology
- 5.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Hematology, by Region, 2019-2032 (USD Billion)
- 5.7. Gastroenterology
- 5.7.1. Global Advanced Therapy Medicinal Products CDMO Market, by Gastroenterology, by Region, 2019-2032 (USD Billion)
- 5.8. Others
- 5.8.1. Global Advanced Therapy Medicinal Products CDMO Market, by Others, by Region, 2019-2032 (USD Billion)
6. Global Advanced Therapy Medicinal Products CDMO Market, by Product
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 6.3. Cell Therapy
- 6.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Cell Therapy, by Region, 2019-2032 (USD Billion)
- 6.4. Gene Therapy
- 6.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Gene Therapy, by Region, 2019-2032 (USD Billion)
7. Global Advanced Therapy Medicinal Products CDMO Market, by Phase
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 7.3. Phase I
- 7.3.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase I, By Region, 2019-2032 (USD Billion)
- 7.4. Phase II
- 7.4.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase II, By Region, 2019-2032 (USD Billion)
- 7.5. Phase III
- 7.5.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase III, By Region, 2019-2032 (USD Billion)
- 7.6. Phase IV
- 7.6.1. Global Advanced Therapy Medicinal Products CDMO Market, by Phase IV, By Region, 2019-2032 (USD Billion)
8. Global Advanced Therapy Medicinal Products CDMO Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
- 8.3. Advanced Therapy Medicinal Products CDMO Market - North America
- 8.3.1. North America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.3.2. North America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.3.3. North America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.3.4. Advanced Therapy Medicinal Products CDMO Market - U.S.
- 8.3.4.1. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.3.4.2. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.3.4.3. U.S.: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.3.5. Advanced Therapy Medicinal Products CDMO Market - Canada
- 8.3.5.1. Canada: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.3.5.2. Canada.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.3.5.3. Canada: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4. Advanced Therapy Medicinal Products CDMO Market - Europe
- 8.4.1. Europe: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.2. Europe.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.3. Europe: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4.4. Advanced Therapy Medicinal Products CDMO Market - UK
- 8.4.4.1. UK: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.4.2. UK.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.4.3. UK: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4.5. Advanced Therapy Medicinal Products CDMO Market - France
- 8.4.5.1. France: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.5.2. France.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.5.3. France: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4.6. Advanced Therapy Medicinal Products CDMO Market - Germany
- 8.4.6.1. Germany: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.6.2. Germany.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.6.3. Germany: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4.7. Advanced Therapy Medicinal Products CDMO Market - Italy
- 8.4.7.1. Italy: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.7.2. Italy.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.7.3. Italy: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4.8. Advanced Therapy Medicinal Products CDMO Market - Spain
- 8.4.8.1. Spain: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.8.2. Spain.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.8.3. Spain: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4.9. Advanced Therapy Medicinal Products CDMO Market - Netherlands
- 8.4.9.1. Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.9.2. Netherlands.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.9.3. Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.4.10. Advanced Therapy Medicinal Products CDMO Market - Russia
- 8.4.10.1. Russia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.4.10.2. Russia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.4.10.3. Russia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.5. Advanced Therapy Medicinal Products CDMO Market - Asia Pacific
- 8.5.1. Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.5.2. Asia Pacific.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.5.3. Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.5.4. Advanced Therapy Medicinal Products CDMO Market - China
- 8.5.4.1. China: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.5.4.2. China.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.5.4.3. China: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.5.5. Advanced Therapy Medicinal Products CDMO Market - India
- 8.5.5.1. India: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.5.5.2. India.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.5.5.3. India: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.5.6. Advanced Therapy Medicinal Products CDMO Market - Malaysia
- 8.5.6.1. Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.5.6.2. Malaysia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.5.6.3. Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.5.7. Advanced Therapy Medicinal Products CDMO Market - Japan
- 8.5.7.1. Japan: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.5.7.2. Japan.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.5.7.3. Japan: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.5.8. Advanced Therapy Medicinal Products CDMO Market - Indonesia
- 8.5.8.1. Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.5.8.2. Indonesia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.5.8.3. Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.5.9. Advanced Therapy Medicinal Products CDMO Market - South Korea
- 8.5.9.1. South Korea: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.5.9.2. South Korea.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.5.9.3. South Korea: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.6. Advanced Therapy Medicinal Products CDMO Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.6.2. Middle East & Africa.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.6.3. Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.6.4. Advanced Therapy Medicinal Products CDMO Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.6.4.2. Saudi Arabia.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.6.4.3. Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.6.5. Advanced Therapy Medicinal Products CDMO Market - UAE
- 8.6.5.1. UAE: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.6.5.2. UAE.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.6.5.3. UAE: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.6.6. Advanced Therapy Medicinal Products CDMO Market - Israel
- 8.6.6.1. Israel: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.6.6.2. Israel.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.6.6.3. Israel: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.6.7. Advanced Therapy Medicinal Products CDMO Market - South Africa
- 8.6.7.1. South Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.6.7.2. South Africa.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.6.7.3. South Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.7. Advanced Therapy Medicinal Products CDMO Market - Latin America
- 8.7.1. Latin America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.7.2. Latin America.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.7.3. Latin America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.7.4. Advanced Therapy Medicinal Products CDMO Market - Mexico
- 8.7.4.1. Mexico: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.7.4.2. Mexico.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.7.4.3. Mexico: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.7.5. Advanced Therapy Medicinal Products CDMO Market - Brazil
- 8.7.5.1. Brazil: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.7.5.2. Brazil.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.7.5.3. Brazil: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- 8.7.6. Advanced Therapy Medicinal Products CDMO Market - Argentina
- 8.7.6.1. Argentina: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- 8.7.6.2. Argentina.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- 8.7.6.3. Argentina: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. AGC Biologics (Switzerland)
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. Bio Elpida (France)
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. BlueReg (France)
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Catalent (US)
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Celonic (Switzerland)
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. CGT Catapult (UK)
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. Lonza (Switzerland)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Medicine Patheon (US)
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Minaris Regenerative (US)
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Rentschler Biopharma SE (US)
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. WuXi Advanced Therapies (US)
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
Product Code: PM4326
List of Tables
- Table 1 Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 2 Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 3 Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 4 Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
- Table 5 North America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 6 North America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 7 North America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 8 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 9 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 10 U.S.: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 11 Canada: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 12 Canada: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 13 Canada: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 14 Europe: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 15 Europe: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 16 Europe: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 17 UK: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 18 UK: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 19 UK: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 20 France: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 21 France: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 22 France: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 23 Germany: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 24 Germany: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 25 Germany: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 26 Italy: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 27 Italy: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 28 Italy: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 29 Spain: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 30 Spain: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 31 Spain: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 32 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 33 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 34 Netherlands: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 35 Russia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 36 Russia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 37 Russia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 38 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 39 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 40 Asia Pacific: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 41 China: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 42 China: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 43 China: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 44 India: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 45 India: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 46 India: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 47 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 48 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 49 Malaysia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 50 Japan: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 51 Japan: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 52 Japan: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 53 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 54 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 55 Indonesia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 56 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 57 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 58 South Korea: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 59 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 60 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 61 Middle East & Africa: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 62 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 63 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 64 Saudi Arabia: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 65 UAE: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 66 UAE: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 67 UAE: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 68 Israel: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 69 Israel: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 70 Israel: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 71 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 72 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 73 South Africa: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 74 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 75 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 76 Latin America: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 77 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 78 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 79 Mexico: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 80 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 81 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 82 Brazil: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
- Table 83 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Indication, 2019-2032 (USD Billion)
- Table 84 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Product, 2019-2032 (USD Billion)
- Table 85 Argentina: Advanced Therapy Medicinal Products CDMO Market, by Phase, 2019-2032 (USD Billion)
List of Figures
- Figure 1. Global Advanced Therapy Medicinal Products CDMO Market, 2019-2032 (USD Billion)
- Figure 2. Integrated Ecosystem
- Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
- Figure 4. Market by Geography
- Figure 5. Porter's Five Forces
- Figure 6. Market by Product
- Figure 7. Global Advanced Therapy Medicinal Products CDMO Market, by Product, 2022 & 2032 (USD Billion)
- Figure 8. Market by Indication
- Figure 9. Global Advanced Therapy Medicinal Products CDMO Market, by Indication, 2022 & 2032 (USD Billion)
- Figure 10. Market by Phase
- Figure 11. Global Advanced Therapy Medicinal Products CDMO Market, by Phase, 2022 & 2032 (USD Billion)
- Figure 12. Advanced Therapy Medicinal Products CDMO Market Assessment, By Geography, 2019-2032 (USD Billion)
- Figure 13. Strategic Analysis - Advanced Therapy Medicinal Products CDMO Market
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.